ELIOR GROUP (ELIOR.PA)

FR0011950732 - Common Stock

2.395  +0.08 (+3.59%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ELIOR. ELIOR was compared to 53 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of ELIOR have multiple concerns. ELIOR is not valued too expensively and it also shows a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year ELIOR has reported negative net income.
In the past year ELIOR had a positive cash flow from operations.
ELIOR had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ELIOR reported negative operating cash flow in multiple years.

1.2 Ratios

ELIOR has a worse Return On Assets (-2.43%) than 75.00% of its industry peers.
ELIOR's Return On Equity of -10.98% is on the low side compared to the rest of the industry. ELIOR is outperformed by 66.67% of its industry peers.
ELIOR has a worse Return On Invested Capital (0.86%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -2.43%
ROE -10.98%
ROIC 0.86%
ROA(3y)-6.07%
ROA(5y)-4.91%
ROE(3y)-25.24%
ROE(5y)-20.33%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 0.50%, ELIOR is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
ELIOR's Operating Margin has declined in the last couple of years.
ELIOR's Gross Margin of 68.29% is in line compared to the rest of the industry. ELIOR outperforms 56.25% of its industry peers.
In the last couple of years the Gross Margin of ELIOR has remained more or less at the same level.
Industry RankSector Rank
OM 0.5%
PM (TTM) N/A
GM 68.29%
OM growth 3YN/A
OM growth 5Y-24.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.05%

1

2. Health

2.1 Basic Checks

ELIOR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ELIOR has more shares outstanding than it did 1 year ago.
ELIOR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ELIOR has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.33, we must say that ELIOR is in the distress zone and has some risk of bankruptcy.
ELIOR's Altman-Z score of 1.33 is in line compared to the rest of the industry. ELIOR outperforms 43.75% of its industry peers.
ELIOR has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
ELIOR has a Debt to Equity ratio (1.51) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACC0.14
WACC6.34%

2.3 Liquidity

A Current Ratio of 0.73 indicates that ELIOR may have some problems paying its short term obligations.
The Current ratio of ELIOR (0.73) is worse than 68.75% of its industry peers.
A Quick Ratio of 0.67 indicates that ELIOR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.67, ELIOR is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.67

4

3. Growth

3.1 Past

ELIOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.06%, which is quite impressive.
Looking at the last year, ELIOR shows a quite strong growth in Revenue. The Revenue has grown by 17.34% in the last year.
ELIOR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.34% yearly.
EPS 1Y (TTM)83.06%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q66.67%
Revenue 1Y (TTM)17.34%
Revenue growth 3Y9.6%
Revenue growth 5Y1.34%
Revenue growth Q2Q24.1%

3.2 Future

Based on estimates for the next years, ELIOR will show a very strong growth in Earnings Per Share. The EPS will grow by 41.31% on average per year.
The Revenue is expected to grow by 5.58% on average over the next years.
EPS Next Y194.84%
EPS Next 2Y89.07%
EPS Next 3Y58.42%
EPS Next 5Y41.31%
Revenue Next Year15.83%
Revenue Next 2Y9.72%
Revenue Next 3Y7.84%
Revenue Next 5Y5.58%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ELIOR. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 11.57, which indicates a very decent valuation of ELIOR.
Based on the Price/Forward Earnings ratio, ELIOR is valued cheaper than 81.25% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.23, ELIOR is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.57

4.2 Price Multiples

ELIOR's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.82

4.3 Compensation for Growth

ELIOR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELIOR's earnings are expected to grow with 58.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.07%
EPS Next 3Y58.42%

0

5. Dividend

5.1 Amount

No dividends for ELIOR!.
Industry RankSector Rank
Dividend Yield N/A

ELIOR GROUP

EPA:ELIOR (4/22/2024, 5:26:19 PM)

2.395

+0.08 (+3.59%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap607.01M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.57
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.43%
ROE -10.98%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.5%
PM (TTM) N/A
GM 68.29%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.73
Quick Ratio 0.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.06%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y194.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.34%
Revenue growth 3Y9.6%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y